Log in to save to my catalogue

Simvastatin Reduces NETosis to Attenuate Severe Asthma by Inhibiting PAD4 Expression

Simvastatin Reduces NETosis to Attenuate Severe Asthma by Inhibiting PAD4 Expression

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9911252

Simvastatin Reduces NETosis to Attenuate Severe Asthma by Inhibiting PAD4 Expression

About this item

Full title

Simvastatin Reduces NETosis to Attenuate Severe Asthma by Inhibiting PAD4 Expression

Publisher

United States: Hindawi

Journal title

Oxidative medicine and cellular longevity, 2023, Vol.2023, p.1493684-13

Language

English

Formats

Publication information

Publisher

United States: Hindawi

More information

Scope and Contents

Contents

Objective. Patients with severe asthma respond poorly to corticosteroids, and their care accounts for more than 60% of the total costs attributed to asthma. Neutrophils form neutrophil extracellular traps (NETs), which play a crucial role in severe asthma. Statins have shown anti-inflammatory effects by reducing NETosis. In this study, we investiga...

Alternative Titles

Full title

Simvastatin Reduces NETosis to Attenuate Severe Asthma by Inhibiting PAD4 Expression

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9911252

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9911252

Other Identifiers

ISSN

1942-0900

E-ISSN

1942-0994

DOI

10.1155/2023/1493684

How to access this item